Amanote Research
Register
Sign In
Discover open access scientific publications
Search, annotate, share and cite publications
Publications by H. Chabernaud
Estimated Costs of Her2-Positive Metastatic Breast Cancer for Patients Initiating an Oral Anticancer Treatment: Results From a French Prospective Observational Study
Value in Health
Medicine
Health Policy
Public Health
Occupational Health
Environmental
Related publications
Therapy Landscape in Patients With Metastatic HER2-Positive Breast Cancer: Data From the PRAEGNANT Real-World Breast Cancer Registry
Cancers
Cancer Research
Oncology
Current Neoadjuvant Treatment Options for HER2 Positive Breast Cancer
Biologics: Targets and Therapy
Oncology
Immunology
Gastroenterology
Pharmacology
Rheumatology
Allergy
Capecitabine in Combination With Docetaxel in First Line in HER2-Negative Metastatic Breast Cancer: An Observational Study
Pathology and Oncology Research
Medicine
Forensic Medicine
Pathology
Oncology
Cancer Research
Optimal Treatment of Early Stage HER2-positive Breast Cancer
Cancer
Cancer Research
Oncology
Oral Paclitaxel in the Treatment of Metastatic Breast Cancer (MBC) Patients.
Journal of Clinical Oncology
Cancer Research
Medicine
Oncology
Exploring Prognostic Factors for HER2-positive Metastatic Breast Cancer: A Retrospective Cohort Study in a Major Swiss Hospital
Swiss Medical Weekly
Medicine
Retrospective Analysis of HER2 Therapy Interruption in Patients Responding to the Treatment in Metastatic HER2+ Breast Cancer
ESMO Open
Cancer Research
Oncology
Current Landscape of Targeted Therapies for Hormone-Receptor Positive, HER2 Negative Metastatic Breast Cancer
Frontiers in Oncology
Cancer Research
Oncology
Emerging Data and Future Directions for CDK4/6 Inhibitor Treatment of Patients With Hormone Receptor Positive HER2-non-amplified Metastatic Breast Cancer
Asia-Pacific Journal of Clinical Oncology
Medicine
Oncology
